Laparoscopic Extravesical Reimplantation in Children with Primary Obstructive Megaureter

López, Manuel; Perez-Etchepare, Eduardo; Bustangi, Nasser; Godik, O.S.; Juricic, Michel; Varlet, François; Gutierrez, Rocio; Culebras, M. Gomez; Gander, Romy; Royo, Gloria; Asensio, M

doi:10.1089/lap.2019.0396

Cited by 13 publications

(3 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…advocated delivering out the ureter through the trocar and completing the tailoring extracorporeally for 3 patients aged 5 to 30 years ( 21 ). Extracorporeal ureteral tailoring followed by ureteroneocystostomy has yielded favorable outcomes for symptomatic POM in both adults and children ( 22 - 24 ).…”

Section: Resultsmentioning

confidence: 99%

“…-Repeated articles -Articles about animal models or gene analysis Selection process Articles were initially screened for inclusion by two reviewers and further discussion was necessary when there were discrepancies Any additional considerations, if applicable The reference lists of the related articles were also searched for any additional included studies 30 years (21). Extracorporeal ureteral tailoring followed by ureteroneocystostomy has yielded favorable outcomes for symptomatic POM in both adults and children (22)(23)(24). Secondly, ureteroneocystostomy with ureteral antireflux management is also challenging in the laparoscopic approach (17).…”

Section: Lurmentioning

confidence: 99%

See 1 more Smart Citation

Minimally invasive ureteral reimplantation or endoscopic management for primary obstructive megaureter: a narrative review of technical modifications and clinical outcomes

Yang

et al. 2022

Transl Androl Urol

View full text Add to dashboard Cite

Background and Objective: Primary obstructive megaureter (POM) has various courses in different age populations. Although open ureteral reimplantation (OUR) remains the standard treatment for symptomatic POM, it is highly invasive with potential complications. In recent years, minimally invasive ureteral reimplantation (MIUR), including laparoscopic ureteral reimplantation (LUR) and roboticassisted laparoscopic ureteral reimplantation (RALUR), and endoscopic management, such as double-J stent insertion, endoureterotomy and endoscopic balloon dilatation (EBD), have been utilized for POM in selected patients. However, few comparable studies between MIUR and endoscopic management have been published to date, and it remains unclear which surgical management is the optimal choice for POM in different age groups. This review provides a comprehensive perspective on technical development and clinical outcomes of MIUR and endoscopic management for POM in pediatric and adult populations. Methods:The PubMed and Web of Science databases were used to comprehensively search English language articles related to MIUR and endoscopic management for POM in pediatric and adult populations up to March 2022. The technical modifications and the relevant clinical outcomes were reviewed. Key Content and Findings: MIUR with various technical modifications related to intracorporealsuturing and ureteroneocystostomy with anti-reflux techniques appears to be as safe and effective for POM in different age groups as the open procedure. Double-J stent insertion should be regarded as a temporary option for infants by achieving internal urinary drainage, as it may present limited success rates and various complications. Endoureterotomy using pure cutting current or laser appears to be a safer, easier, and less invasive alternative to open surgical management. While EBD has emerged as a definite treatment for POM in the pediatric population, it is debatable whether EBD can substitute for MIUR in adult patients. Conclusions:The safety and feasibility of MIUR and endoscopic management in patients from all age groups still need further investigation.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Lurmentioning

confidence: 99%

Minimally invasive ureteral reimplantation or endoscopic management for primary obstructive megaureter: a narrative review of technical modifications and clinical outcomes

Yang

et al. 2022

Transl Androl Urol

View full text Add to dashboard Cite

show abstract

“…Reports on laparoscopic and robotic correction of POM in children are still relatively rare. Small series have been published treating POM with laparoscopic [ 37 ] and robotic ureteral reimplantation [ 38 – 40 ], and results seem comparable to those of open repair. However, more data and long-term follow up studies are needed to ascertain this.…”

Section: Discussionmentioning

confidence: 99%

High-pressure balloon dilatation of primary obstructive megaureter in children: a systematic review

2023

View full text Add to dashboard Cite

Objective We aimed to evaluate the effectiveness and complication rates of endoscopic high-pressure balloon dilatation (HPBD) in treating primary obstructive megaureter (POM) in children based on current literature. Specifically, we wanted to clarify the evidence on the use of HPBD in children under one year of age. Methods A systematic search of the literature was performed via several databases. The preferred reporting items for systematic reviews and meta-analyses guidelines were followed. The primary outcomes studied in this systematic review were the effectiveness of HBPD in relieving obstruction and reducing hydroureteronephrosis in children. The secondary outcome was to study the complication rate of endoscopic high-pressure balloon dilatation. Studies that reported one or both of these outcomes (n = 13) were considered eligible for inclusion in this review. Results HPBD significantly decreased both ureteral diameter (15.8 mm [range 2–30] to 8.0 mm [0–30], p = 0.00009) and anteroposterior diameter of renal pelvis (16.7 mm [0–46] to 9.7 mm [0–36], p = 0.00107). The success rate was 71% after one HPBD and 79% after two HPBD. The median follow-up time was 3.6 years (interquartile range 2.2–6.4 years). A complication rate of 33% was observed, but no Clavien–Dindo grade IV–V complications were reported. Postoperative infections and VUR were detected in 12% and 7.8% of cases, respectively. For children under one year of age, outcomes of HPBD seem to be similar to those in older children. Conclusions This study indicates that HPBD appears to be safe and can be used as the first-line treatment for symptomatic POM. Further comparative studies are needed addressing the effect of treatment in infants, and also long-term outcomes of the treatment. Due to the nature of POM, identifying those patients who will benefit from HPBD remains challenging.

show abstract

Laparoscopic Management of the Primary Obstructive Megaureter

López

Gander

Royo

et al. 2022

Minimally Invasive Techniques in Pediatric Urology

View full text Add to dashboard Cite

Laparoscopic Extravesical Reimplantation in Children with Primary Obstructive Megaureter

Cited by 13 publications

References 33 publications

Minimally invasive ureteral reimplantation or endoscopic management for primary obstructive megaureter: a narrative review of technical modifications and clinical outcomes

Minimally invasive ureteral reimplantation or endoscopic management for primary obstructive megaureter: a narrative review of technical modifications and clinical outcomes

High-pressure balloon dilatation of primary obstructive megaureter in children: a systematic review

Laparoscopic Management of the Primary Obstructive Megaureter

Contact Info

Product

Resources

About